Mardi Dier
Finanzdirektor/CFO bei MADRIGAL PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Ms. Mardi C. Dier ist Chief Financial Officer & Executive Vice President bei Ultragenyx Pharmaceutical, Inc. und ein unabhängiges Mitglied des Verwaltungsrats bei Oric Pharmaceuticals, Inc. und Adamas Pharmaceuticals, Inc. Sie ist Mitglied des Board of Directors bei Prelude Therapeutics, Inc. und Oric Pharmaceuticals, Inc. und Adamas Pharmaceuticals, Inc. Frau Dier war zuvor als CFO, Chief Business Officer & Executive VP bei Portola Pharmaceuticals, Inc. beschäftigt, als Vice President-Investor Relations bei Chiron Corp., als Director-Investment Banking bei Prudential Equity Group LLC, als Senior Accountant bei KPMG LLP, als Senior Accountant bei KPMG Peat Marwick LLP und als Director-Investment Banking bei Prudential Securities. Sie war auch im Vorstand von Jewish Vocational Service, Inc. und Futures Strategic Trust. Sie erhielt ihren Bachelor-Abschluss von der Stanford University und einen MBA von der UCLA Anderson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.03.2024 | 8 875 ( 0,04% ) | 2 Mio $ | 30.04.2024 | |
| 16.06.2023 | 10 000 ( 0,02% ) | 40 400 $ | 30.04.2024 | |
ACELYRIN, INC.
0,01% | 09.05.2023 | 7 306 ( 0,01% ) | 30 977 $ | 30.04.2024 |
ORIC PHARMACEUTICALS INC
-.--% | 31.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Mardi Dier
| Unternehmen | Position | Beginn |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 02.03.2020 |
| PRELUDE THERAPEUTICS INCORPORATED | Direktor/Vorstandsmitglied | 01.08.2020 |
| MADRIGAL PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 11.03.2024 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Berater | - |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | 03.06.2021 |
Ehemalige bekannte Positionen von Mardi Dier
| Unternehmen | Position | Ende |
|---|---|---|
| ACELYRIN, INC. | Finanzdirektor/CFO | 02.08.2023 |
| ULTRAGENYX PHARMACEUTICAL INC. | Finanzdirektor/CFO | 15.11.2022 |
| ADAMAS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 09.06.2021 |
| PORTOLA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.07.2020 |
| ░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Mardi Dier
| UCLA Anderson School of Management | Masters Business Admin |
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| ACELYRIN, INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Futures Strategic Trust | Finance |
| KPMG Peat Marwick LLP | Commercial Services |
Prudential Equity Group LLC
 Prudential Equity Group LLC Investment Banks/BrokersFinance A unit of Prudential Financial, Inc. (NYSE: PRU), Prudential Equity Group LLC is a broker/dealer headquartered in New York City with additional offices in Chicago, Kansas City, Missouri, Menlo Park, California and San Francisco. The firm provides indpendent equity research, sales and trading to domestic and international institutional clients | Finance |
Jewish Vocational Service, Inc.
 Jewish Vocational Service, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Vocational Service, Inc. operates as a non-profit organization which provides educational and vocational services. It offers education, career services, workforce development, and community services. The company was founded in 1938 and is headquartered in Boston, MA. | Commercial Services |
| Prudential Securities | Finance |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Synthekine, Inc.
Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
